[Effect of vitamin K2 and estrogen administration on bone formation].
Aisaka
Kohzo
K
Department of Obstetrics and Gynecology, Hamada Hospital.
D000596:Amino Acids / Q000652:urine; D015415:Biomarkers / Q000097:blood / Q000652:urine; D015519:Bone Density; D001862:Bone Resorption / Q000175:diagnosis; D004359:Drug Therapy, Combination; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008159:Lumbar Vertebrae / Q000503:physiopathology; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D008593:Menopause; D015675:Osteocalcin / Q000097:blood; D010012:Osteogenesis; D010024:Osteoporosis / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control*; D016896:Treatment Outcome; D024482:Vitamin K 2 / Q000627:therapeutic use*
D000596:Amino Acids; D015415:Biomarkers; D004966:Estrogens, Conjugated (USP); D015675:Osteocalcin; D024482:Vitamin K 2; C036020:deoxypyridinoline; D017258:Medroxyprogesterone Acetate